Invention Grant
- Patent Title: Heterocyclic compound
- Patent Title (中): 杂环化合物
-
Application No.: US14325564Application Date: 2014-07-08
-
Publication No.: US09199963B2Publication Date: 2015-12-01
- Inventor: Hideyuki Igawa , Masashi Takahashi , Keiko Kakegawa , Minoru Ikoma , Jumpei Aida
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2013-143940 20130709
- Main IPC: C07D401/00
- IPC: C07D401/00 ; A61K31/4965 ; C07D401/04 ; C07D401/14 ; C07D409/14 ; C07D417/14 ; C07D405/14
Abstract:
Provided is a compound having a melanin-concentrating hormone receptor antagonistic action and is useful as an agent for the prophylaxis or treatment of obesity and the like. A compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
Public/Granted literature
- US20150018373A1 HETEROCYCLIC COMPOUND Public/Granted day:2015-01-15
Information query
